Biosimulation Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029

15.8%
CAGR (2023-2029)
2.49 USD Bn.
Market Size
316
Report Pages
128
Market Tables

Overview

Global Biosimulation Market size is expected to reach US$ 6.98 Bn. by year 2029 at a CAGR of 15.8% during the forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Biosimulation MarketTo know about the Research Methodology:-Request Free Sample Report

Global Biosimulation Market is segmented by product & services, delivery mode, application, end user, and geography. Biosimulation Software segment is expected to register highest growth in forecast period. Growing adoption of biosimulation software by pharmaceutical and research organizations will fuel the Biosimulation Software segment growth. Delivery mode segment is classified as subscription and ownership model.

Subscription model sub segment is estimated to hold the largest market share in forecast period. Subscription model provides various advantages such as cost-effectiveness, interoperability, and flexibility these will result into increasing share of subscription model market. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America.

Increase in R&D investments in the pharmaceutical and biotechnology industries are trending the overall Global market. Issues related to lack of standardization may hamper the market growth. North America is going to emerge as one of the higher growth regions in forecast period followed by APAC and Europe. Growth in the biotechnology and pharmaceutical industry, a large number of ongoing drug development processes will fuel the Biosimulation Market in North America region.

Global Biosimulation Market Research Methodology

Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Global Biosimulation Market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of this market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Biosimulation Market globally.

Key Highlights:

Global Biosimulation Market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Biosimulation Market

Global Biosimulation Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

The Global Biosimulation Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Biosimulation Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Biosimulation Market are also profiled.

Key Target Audience:

Venture Capitalists, Private Equity Firms, And Startup Companies
Contract research organizations (CROs)
Market research and consulting companies
Biotechnology and pharmaceutical companies
Regulatory authorities
Biosimulation product manufacturers, vendors, and distributors
Government Bodies And Healthcare Associations/Institutions

Research report categorizes the Global Biosimulation Market based on product & services, delivery mode, application, end user, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Biosimulation Market with key developments in companies and market trends.

Global Biosimulation Market Scope: Inquire before buying

Biosimulation Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.49 Bn.
Forecast Period 2023 to 2029 CAGR: 15.8 % Market Size in 2029: US $ 6.98 Bn.
Segments Covered: by Delivery Mode Subscription Models
Ownership Models
by Product & Services Software
Services
by Application Drug Development
Drug Discovery
Other Application
by End-User Pharmaceutical and Biotechnology Companies
Research Institutes
Contract Research Organizations
Regulatory Authorities
Other End Users

Global Biosimulation Market, by Region:

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Player

1. Inosim Software
2. Nuventra Pharma
3. Insilico Biotechnology
4. Leadinvent Technologies
5. In Silico Biosciences
6. Evidera
7. Physiomics
8. Genedata
9. Rosa
10. Chemical Computing Group
11. Advanced Chemistry Development
12. Schrödinger
13. Dassault Systèmes
14. Simulation Plus
15. Certara
16. Physiomics
17. Rhenovia Pharma Ltd
18. Entelos, Inc.
19. Leadscope Inc
20. Acceryls Inc.

Frequently Asked Questions:

1. What is the growth rate of Global Biosimulation Market?
Ans: The Global Biosimulation Market is growing at a CAGR of 15.8% during forecasting period 2023-2029.

2. What is scope of the Global Biosimulation market report?
Ans: Global Biosimulation Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

3. Who are the key players in Global Biosimulation market?
Ans: The important key players in the Global Biosimulation Market are – Inosim Software, Nuventra Pharma, Insilico Biotechnology, Leadinvent Technologies, In Silico Biosciences, Evidera, Physiomics, Genedata, Rosa, Chemical Computing Group, Advanced Chemistry Development, Schrödinger, Dassault Systèmes, Simulation Plus, Certara, Physiomics, Rhenovia Pharma Ltd, Entelos, Inc., Leadscope Inc, and Acceryls Inc.

4. What is the study period of this market?
Ans: The Global Biosimulation Market is studied from 2022 to 2029.

Table of Contents

1. Biosimulation Market: Research Methodology 2. Biosimulation Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Biosimulation Market: Dynamics 3.1. Biosimulation Market Trends by Region 3.1.1. North America Biosimulation Market Trends 3.1.2. Europe Biosimulation Market Trends 3.1.3. Asia Pacific Biosimulation Market Trends 3.1.4. Middle East and Africa Biosimulation Market Trends 3.1.5. South America Biosimulation Market Trends 3.2. Biosimulation Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Biosimulation Market Drivers 3.2.1.2. North America Biosimulation Market Restraints 3.2.1.3. North America Biosimulation Market Opportunities 3.2.1.4. North America Biosimulation Market Challenges 3.2.2. Europe 3.2.2.1. Europe Biosimulation Market Drivers 3.2.2.2. Europe Biosimulation Market Restraints 3.2.2.3. Europe Biosimulation Market Opportunities 3.2.2.4. Europe Biosimulation Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Biosimulation Market Drivers 3.2.3.2. Asia Pacific Biosimulation Market Restraints 3.2.3.3. Asia Pacific Biosimulation Market Opportunities 3.2.3.4. Asia Pacific Biosimulation Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Biosimulation Market Drivers 3.2.4.2. Middle East and Africa Biosimulation Market Restraints 3.2.4.3. Middle East and Africa Biosimulation Market Opportunities 3.2.4.4. Middle East and Africa Biosimulation Market Challenges 3.2.5. South America 3.2.5.1. South America Biosimulation Market Drivers 3.2.5.2. South America Biosimulation Market Restraints 3.2.5.3. South America Biosimulation Market Opportunities 3.2.5.4. South America Biosimulation Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Software Solutions for Biosimulation 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Industry 3.8. Analysis of Government Schemes and Initiatives Industry 3.9. The Global Pandemic Impact on Biosimulation Market 4. Biosimulation Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 4.1.1. Subscription Models 4.1.2. Ownership Models 4.2. Biosimulation Market Size and Forecast, by Product & Services (2023-2030) 4.2.1. Software 4.2.2. Services 4.3. Biosimulation Market Size and Forecast, By Application (2023-2030) 4.3.1. Drug Development 4.3.2. Drug Discovery 4.3.3. Other Application 4.4. Biosimulation Market Size and Forecast, By End-User (2023-2030) 4.4.1. Pharmaceutical and Biotechnology Companies 4.4.2. Research Institutes 4.4.3. Contract Research Organizations 4.4.4. Regulatory Authorities 4.4.5. Other End Users 4.5. Biosimulation Market Size and Forecast, By Region (2023-2030) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Biosimulation Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 5.1.1. Subscription Models 5.1.2. Ownership Models 5.2. North America Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 5.2.1. Software 5.2.2. Services 5.3. North America Biosimulation Market Size and Forecast, By Application (2023-2030) 5.3.1. Drug Development 5.3.2. Drug Discovery 5.3.3. Other Application 5.4. North America Biosimulation Market Size and Forecast, By End-User (2023-2030) 5.4.1. Pharmaceutical and Biotechnology Companies 5.4.2. Research Institutes 5.4.3. Contract Research Organizations 5.4.4. Regulatory Authorities 5.4.5. Other End Users 5.5. North America Biosimulation Market Size and Forecast, by Country (2023-2030) 5.5.1. United States 5.5.1.1. United States Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 5.5.1.1.1. Subscription Models 5.5.1.1.2. Ownership Models 5.5.1.2. United States Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 5.5.1.2.1. Software 5.5.1.2.2. Services 5.5.1.3. United States Biosimulation Market Size and Forecast, By Application (2023-2030) 5.5.1.3.1. Drug Development 5.5.1.3.2. Drug Discovery 5.5.1.3.3. Other Application 5.5.1.4. United States Biosimulation Market Size and Forecast, By End-User (2023-2030) 5.5.1.4.1. Pharmaceutical and Biotechnology Companies 5.5.1.4.2. Research Institutes 5.5.1.4.3. Contract Research Organizations 5.5.1.4.4. Regulatory Authorities 5.5.1.4.5. Other End Users 5.5.2. Canada 5.5.2.1. Canada Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 5.5.2.1.1. Subscription Models 5.5.2.1.2. Ownership Models 5.5.2.2. Canada Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 5.5.2.2.1. Software 5.5.2.2.2. Services 5.5.2.3. Canada Biosimulation Market Size and Forecast, By Application (2023-2030) 5.5.2.3.1. Drug Development 5.5.2.3.2. Drug Discovery 5.5.2.3.3. Other Application 5.5.2.4. Canada Biosimulation Market Size and Forecast, By End-User (2023-2030) 5.5.2.4.1. Pharmaceutical and Biotechnology Companies 5.5.2.4.2. Research Institutes 5.5.2.4.3. Contract Research Organizations 5.5.2.4.4. Regulatory Authorities 5.5.2.4.5. Other End Users 5.5.3. Mexico 5.5.3.1. Mexico Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 5.5.3.1.1. Subscription Models 5.5.3.1.2. Ownership Models 5.5.3.2. Mexico Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 5.5.3.2.1. Software 5.5.3.2.2. Services 5.5.3.3. Mexico Biosimulation Market Size and Forecast, By Application (2023-2030) 5.5.3.3.1. Drug Development 5.5.3.3.2. Drug Discovery 5.5.3.3.3. Other Application 5.5.3.4. Mexico Biosimulation Market Size and Forecast, By End-User (2023-2030) 5.5.3.4.1. Pharmaceutical and Biotechnology Companies 5.5.3.4.2. Research Institutes 5.5.3.4.3. Contract Research Organizations 5.5.3.4.4. Regulatory Authorities 5.5.3.4.5. Other End Users 6. Europe Biosimulation Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.2. Europe Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.3. Europe Biosimulation Market Size and Forecast, By Application (2023-2030) 6.4. Europe Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5. Europe Biosimulation Market Size and Forecast, by Country (2023-2030) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.1.2. United Kingdom Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.1.3. United Kingdom Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.1.4. United Kingdom Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.2. France 6.5.2.1. France Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.2.2. France Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.2.3. France Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.2.4. France Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.3. Germany 6.5.3.1. Germany Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.3.2. Germany Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.3.3. Germany Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.3.4. Germany Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.4. Italy 6.5.4.1. Italy Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.4.2. Italy Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.4.3. Italy Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.4.4. Italy Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.5. Spain 6.5.5.1. Spain Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.5.2. Spain Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.5.3. Spain Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.5.4. Spain Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.6. Sweden 6.5.6.1. Sweden Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.6.2. Sweden Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.6.3. Sweden Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.6.4. Sweden Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.7. Austria 6.5.7.1. Austria Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.7.2. Austria Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.7.3. Austria Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.7.4. Austria Biosimulation Market Size and Forecast, By End-User (2023-2030) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 6.5.8.2. Rest of Europe Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 6.5.8.3. Rest of Europe Biosimulation Market Size and Forecast, By Application (2023-2030) 6.5.8.4. Rest of Europe Biosimulation Market Size and Forecast, By End-User (2023-2030) 7. Asia Pacific Biosimulation Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.2. Asia Pacific Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.3. Asia Pacific Biosimulation Market Size and Forecast, By Application (2023-2030) 7.4. Asia Pacific Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5. Asia Pacific Biosimulation Market Size and Forecast, by Country (2023-2030) 7.5.1. China 7.5.1.1. China Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.1.2. China Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.1.3. China Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.1.4. China Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.2. S Korea 7.5.2.1. S Korea Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.2.2. S Korea Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.2.3. S Korea Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.2.4. S Korea Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.3. Japan 7.5.3.1. Japan Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.3.2. Japan Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.3.3. Japan Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.3.4. Japan Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.4. India 7.5.4.1. India Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.4.2. India Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.4.3. India Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.4.4. India Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.5. Australia 7.5.5.1. Australia Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.5.2. Australia Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.5.3. Australia Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.5.4. Australia Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.6. Indonesia 7.5.6.1. Indonesia Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.6.2. Indonesia Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.6.3. Indonesia Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.6.4. Indonesia Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.7. Malaysia 7.5.7.1. Malaysia Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.7.2. Malaysia Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.7.3. Malaysia Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.7.4. Malaysia Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.8. Vietnam 7.5.8.1. Vietnam Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.8.2. Vietnam Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.8.3. Vietnam Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.8.4. Vietnam Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.9. Taiwan 7.5.9.1. Taiwan Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.9.2. Taiwan Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.9.3. Taiwan Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.9.4. Taiwan Biosimulation Market Size and Forecast, By End-User (2023-2030) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 7.5.10.2. Rest of Asia Pacific Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 7.5.10.3. Rest of Asia Pacific Biosimulation Market Size and Forecast, By Application (2023-2030) 7.5.10.4. Rest of Asia Pacific Biosimulation Market Size and Forecast, By End-User (2023-2030) 8. Middle East and Africa Biosimulation Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 8.1. Middle East and Africa Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 8.2. Middle East and Africa Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 8.3. Middle East and Africa Biosimulation Market Size and Forecast, By Application (2023-2030) 8.4. Middle East and Africa Biosimulation Market Size and Forecast, By End-User (2023-2030) 8.5. Middle East and Africa Biosimulation Market Size and Forecast, by Country (2023-2030) 8.5.1. South Africa 8.5.1.1. South Africa Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 8.5.1.2. South Africa Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 8.5.1.3. South Africa Biosimulation Market Size and Forecast, By Application (2023-2030) 8.5.1.4. South Africa Biosimulation Market Size and Forecast, By End-User (2023-2030) 8.5.2. GCC 8.5.2.1. GCC Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 8.5.2.2. GCC Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 8.5.2.3. GCC Biosimulation Market Size and Forecast, By Application (2023-2030) 8.5.2.4. GCC Biosimulation Market Size and Forecast, By End-User (2023-2030) 8.5.3. Nigeria 8.5.3.1. Nigeria Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 8.5.3.2. Nigeria Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 8.5.3.3. Nigeria Biosimulation Market Size and Forecast, By Application (2023-2030) 8.5.3.4. Nigeria Biosimulation Market Size and Forecast, By End-User (2023-2030) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 8.5.4.2. Rest of ME&A Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 8.5.4.3. Rest of ME&A Biosimulation Market Size and Forecast, By Application (2023-2030) 8.5.4.4. Rest of ME&A Biosimulation Market Size and Forecast, By End-User (2023-2030) 9. South America Biosimulation Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 9.1. South America Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 9.2. South America Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 9.3. South America Biosimulation Market Size and Forecast, By Application (2023-2030) 9.4. South America Biosimulation Market Size and Forecast, By End-User (2023-2030) 9.5. South America Biosimulation Market Size and Forecast, by Country (2023-2030) 9.5.1. Brazil 9.5.1.1. Brazil Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 9.5.1.2. Brazil Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 9.5.1.3. Brazil Biosimulation Market Size and Forecast, By Application (2023-2030) 9.5.1.4. Brazil Biosimulation Market Size and Forecast, By End-User (2023-2030) 9.5.2. Argentina 9.5.2.1. Argentina Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 9.5.2.2. Argentina Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 9.5.2.3. Argentina Biosimulation Market Size and Forecast, By Application (2023-2030) 9.5.2.4. Argentina Biosimulation Market Size and Forecast, By End-User (2023-2030) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Biosimulation Market Size and Forecast, By Delivery Mode (2023-2030) 9.5.3.2. Rest Of South America Biosimulation Market Size and Forecast, By Product & Services (2023-2030) 9.5.3.3. Rest Of South America Biosimulation Market Size and Forecast, By Application (2023-2030) 9.5.3.4. Rest Of South America Biosimulation Market Size and Forecast, By End-User (2023-2030) 10. Global Biosimulation Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2023) 10.3.5. Company Locations 10.4. Leading Biosimulation Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Inosim Software 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Recent Developments 11.2. Insilico Biotechnology 11.3. Leadinvent Technologies 11.4. In Silico Biosciences 11.5. Evidera 11.6. Physiomics 11.7. Genedata 11.8. Rosa 11.9. Chemical Computing Group 11.10. Advanced Chemistry Development 11.11. Schrödinger 11.12. Dassault Systèmes 11.13. Simulation Plus 11.14. Certara 11.15. Physiomics 11.16. Rhenovia Pharma Ltd 11.17. Entelos, Inc. 11.18. Leadscope Inc 11.19. Acceryls Inc. 12. Key Findings 13. Industry Recommendations

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample